Short peptide analogs as alternatives to collagen in pro-regenerative corneal implants
Autor: | Monika Kozak Ljunggren, Michel Haagdorens, Mohammad Mirazul Islam, Jaganmohan Reddy Jangamreddy, May Griffith, Nadia Zakaria, Philip N. Lewis, Ayan Samanta, Per Fagerholm, Emilio I. Alarcon, Keith M. Meek, Oleksiy Buznyk, Aneta Liszka |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Swine Biomaterialvetenskap Biomedical Engineering Peptide 02 engineering and technology Exosomes Biochemistry Article Polyethylene Glycols Cornea Biomaterials 03 medical and health sciences Implants Experimental Tissue engineering Collagen-like peptide medicine Animals Humans Regeneration Recombinant human collagen Molecular Biology ComputingMethodologies_COMPUTERGRAPHICS Cell Line Transformed chemistry.chemical_classification Physics Regeneration (biology) Biochemistry and Molecular Biology General Medicine Extracellular vesicle 021001 nanoscience & nanotechnology In vitro 3. Good health Cell biology 030104 developmental biology medicine.anatomical_structure chemistry Mechanism of action Self-healing hydrogels Biomaterials Science Swine Miniature Collagen medicine.symptom Peptides 0210 nano-technology Biokemi och molekylärbiologi Biotechnology |
Zdroj: | Acta biomaterialia Acta Biomaterialia |
ISSN: | 1742-7061 |
Popis: | Graphical abstract Short collagen-like peptides (CLPs) are being proposed as alternatives to full-length collagen for use in tissue engineering, on their own as soft hydrogels, or conjugated to synthetic polymer for mechanical strength. However, despite intended clinical use, little is known about their safety and efficacy, mechanism of action or degree of similarity to the full-length counterparts they mimic. Here, we show the functional equivalence of a CLP conjugated to polyethylene glycol (CLP-PEG) to full-length recombinant human collagen in vitro and in promoting stable regeneration of corneal tissue and nerves in a pre-clinical mini-pig model. We also show that these peptide analogs exerted their pro-regeneration effects through stimulating extracellular vesicle production by host cells. Our results support future use of CLP-PEG implants for corneal regeneration, suggesting the feasibility of these or similar peptide analogs in clinical application in the eye and other tissues. Statement of significance Although biomaterials comprising full-length recombinant human collagen and extracted animal collagen have been evaluated and used clinically, these macromolecules provide only a limited number of functional groups amenable to chemical modification or crosslinking and are demanding to process. Synthetic, customizable analogs that are functionally equivalent, and can be readily scaled-up are therefore very desirable for pre-clinical to clinical translation. Here, we demonstrate, using cornea regeneration as our test bed, that collagen-like-peptides conjugated to multifunctional polyethylene glycol (CLP-PEG) when grafted into mini-pigs as corneal implants were functionally equivalent to recombinant human collagen-based implants that were successfully tested in patients. We also show for the first time that these materials affected regeneration through stimulation of extracellular vesicle production by endogenous host cells that have migrated into the CLP-PEG scaffolds. |
Databáze: | OpenAIRE |
Externí odkaz: |